VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68 | -62.2% | 7,231 | -1.5% | 0.00% | -57.1% |
| Q2 2023 | $180 | +4.7% | 7,344 | -0.6% | 0.01% | 0.0% |
| Q1 2023 | $172 | -8.5% | 7,386 | -0.4% | 0.01% | -12.5% |
| Q4 2022 | $188 | -99.9% | 7,412 | -16.9% | 0.01% | +14.3% |
| Q3 2022 | $172,000 | -40.1% | 8,917 | -20.8% | 0.01% | -12.5% |
| Q2 2022 | $287,000 | +282.7% | 11,253 | +283.7% | 0.01% | +300.0% |
| Q1 2022 | $75,000 | -46.8% | 2,933 | -12.8% | 0.00% | -33.3% |
| Q4 2021 | $141,000 | -2.8% | 3,362 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $145,000 | -11.0% | 3,336 | -3.5% | 0.00% | 0.0% |
| Q2 2021 | $163,000 | – | 3,456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |